STOCK TITAN

Windward Bio CEO reports 4.58M-share holding

Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
3

Rhea-AI Filing Summary

Windward Bio Group AG (WWB) Chief Executive Officer Luca Santarelli reported direct holdings of 4,578,110 common shares and an employee share option covering 163,854 common shares as of November 12, 2026. The option has a $0.0200 exercise price and expires April 30, 2036. It vested or will vest in 36 equal monthly installments on the last day of each relevant month beginning April 30, 2026, subject to continuous service on each vesting date. The exercise price reflects conversion from CHF at an exchange rate of $1.122 to CHF 1.00 as of November 6, 2026.

Insider Santarelli Luca
Role Chief Executive Officer
Type Security Shares Price Value
Holding Employee Share Option (Right to Buy) F2, F1 -- -- --
Holding Common Shares -- -- --
Holdings: Employee Share Option (Right to Buy) — 163,854 options (Direct); Common Shares — 4,578,110 shares (Direct)
Footnotes (2)
  1. F1. This option vested or will vest in 36 equal monthly installments on the last day of the relevant month commencing on April 30, 2026, subject to the Reporting Person's continuous service as of each such vesting date.
  2. F2. The exercise price is in US Dollars and reflects the conversion of CHF to USD at an exchange rate of $1.122 to CHF 1.00 as of November 6, 2026.
Common shares held directly 4,578,110 shares As of November 12, 2026
Shares underlying employee option 163,854 shares Direct option holding as of November 12, 2026
Exercise price $0.0200 per share The price reflects conversion from CHF at $1.122 to CHF 1.00 as of November 6, 2026
Option expiration April 30, 2036 Employee share option covering common shares
Vesting installments 36 equal monthly installments Beginning April 30, 2026; subject to continuous service on each vesting date
Employee Share Option (Right to Buy) technical
"Employee Share Option (Right to Buy)"
continuous service technical
"subject to the Reporting Person's continuous service as of each such vesting date"
CHF financial
"conversion of CHF to USD at an exchange rate of $1.122 to CHF 1.00"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares does WWB CEO Luca Santarelli report holding?

Luca Santarelli reported 4,578,110 common shares held directly as of November 12, 2026.

What are the vesting terms for Luca Santarelli’s WWB share option?

The option covering 163,854 common shares vested or will vest in 36 equal monthly installments on the last day of each relevant month beginning April 30, 2026, subject to continuous service on each vesting date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Santarelli Luca

(Last)(First)(Middle)
C/O WINDWARD BIO GROUP AG
AESCHENPLATZ 6

(Street)
BASEL4052

(City)(State)(Zip)

SWITZERLAND

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
11/12/2026
3. Issuer Name and Ticker or Trading Symbol
WINDWARD BIO GROUP AG [ WWB ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Shares4,578,110D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Share Option (Right to Buy) (1)04/30/2036Common Shares163,854$0.02(2)D
Explanation of Responses:
1. This option vested or will vest in 36 equal monthly installments on the last day of the relevant month commencing on April 30, 2026, subject to the Reporting Person's continuous service as of each such vesting date.
2. The exercise price is in US Dollars and reflects the conversion of CHF to USD at an exchange rate of $1.122 to CHF 1.00 as of November 6, 2026.
/s/ Scott Applebaum, Attorney-in-Fact11/12/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Keep reading